Leonard Riley, MD

Professional Background

Dr. Riley is an Assistant Professor of medicine at the University of Kansas Medical Center and Kansas City Veterans Affairs Medical Center who is board-certified in pulmonary disease and critical care medicine. His clinical interests include diagnosing and managing people with alpha-1 antitrypsin deficiency and chronic obstructive pulmonary disease.

Dr. Riley received his medical degree from Ross University and proceeded to complete his Internal Medicine Residency training at the University of Kansas Medical Center. He then completed his Pulmonary and Critical Care Fellowship at the University of Florida in Gainesville, Florida.

• BS, Biochemistry and Biophysical Sciences, University of Houston, Houston, Texas
• MD, Medicine, Ross University, Commonwealth of Dominica
• Residency, Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas
• Residency, Chief Resident - Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas
• Clinical Fellowship, Pulmonary and Critical Care Medicine, University of Florida, Gainesville, Florida

• Medical license, Florida Department of Health
• Medical license, Kansas State Board of Healing Arts

• American Thoracic Society, Member, 2017 - Present
• Chest, Member, 2017 - Present

Research

Overview

Dr. Riley's main research interests are investigating ways to improve testing, detection, and clinical outcomes for individuals with alpha-1 antitrypsin deficiency (AATD). He has published several articles and has multiple projects to improve testing, understanding the disparities in people who are tested for AATD, and their clinical outcomes. Additionally, he serves as the clinical director for the AATD clinic at the Kansas City Veterans Affairs Medical Center and University of Kansas Medical Center.

• Impact of a Multicenter Best Practice Alert to Improve AATD Testing and Detection, Alpha-1 Foundation, PI

• Riley, Leonard, Sriram, Aryaman, Brantly, Mark, Lascano, Jorge. 2023. Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency. American Journal of Medicine
• Riley, Leonard, Brunson, Cory, Eydgahi, Soroush, Brantly, Mark, Lascano, Jorge. 2023. Development of a Risk Score to Increase Detection of Severe Alpha-1 Antitrypsin Deficiency. European Respiratory Journal Open Research
• Lascano, Jorge, Riley, Leonard, Kohdarayi, Nazli, Brantly, Mark. 2023. Augmentation Therapy Modulates Systemic Inflammation in Individuals with Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease.. Chronic Obstructive Pulmonary Disease
• Kokturk, Nurdan, Khodayari, Nazli, Lascano, Jorge, Riley, Leonard, Brantly, Mark. 2023. Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function. Respiratory Research
• Campos, Michael, Hagenlocker, Brian, Lascano, Jorge, Riley, Leonard. 2023. Impact of a Computerized Clinical Decision Support System to Improve COPD Diagnosis and Testing for Alpha-1 Antitrypsin Deficiency . Annals of American Thoracic Society
• Riley, Leonard, Lascano, Jorge. 2022. Labelling Alpha-1 antitrypsin deficiency in the medical record - A call to action. Respiratory Medicine
• Jung, Frederick, Riley, Leonard, Lascano, Jorge. 2022. Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis. European Respiratory Journal Open Research
• Riley, Leonard, Lascano, Jorge. 2021. Gender and racial disparities in lung transplantation in the United States. Journal of Heart Lung Transplant
• Riley, Leonard, Lascano, Jorge. 2020. Clinical outcomes and survival following lung transplantation in patients with Alpha-1 antitrypsin deficiency. Respiratory Medicine
• Riley, Leonard, Brantly, Mark, Ataya, Ali. 2019. A Woman With Dyspnea and Bronchiectasis. JAMA: Journal of American Medical Association